Condensed Statements Of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Condensed Statements Of Operations [Abstract]
SALES	$ 2,796	$ 3,356	$ 8,896	$ 10,941
COST OF GOODS SOLD	1,485	2,507	4,659	6,431
Gross profit	1,311	849	4,237	4,510
COSTS AND EXPENSES
Sales and marketing	657	1,313	2,196	4,839
General and administrative	449	527	1,404	1,773
Research and development	298	408	969	1,281
Change in value of acquisition consideration		(12)		(105)
Medical device tax	44	52	140	172
Amortization of identifiable intangible assets	16	28	56	72
Total costs and expenses	1,464	2,316	4,765	8,032
OPERATING LOSS	(153)	(1,467)	(528)	(3,522)
INTEREST EXPENSE	(190)	(178)	(594)	(516)
FOREIGN CURRENCY EXCHANGE (GAIN)/LOSS	(6)	(1)	(12)	1
LOSS BEFORE INCOME TAXES	(349)	(1,646)	(1,134)	(4,037)
INCOME TAX EXPENSE		18	9	46
NET LOSS	$ (349)	$ (1,664)	$ (1,143)	$ (4,083)
NET LOSS PER COMMON SHARE - BASIC	$ (0.02)	$ (0.08)	$ (0.05)	$ (0.19)
NET LOSS PER COMMON SHARE - DILUTED	$ (0.02)	$ (0.08)	$ (0.05)	$ (0.19)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC	21,838	21,326	21,701	21,195
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED	21,838	21,326	21,701	21,195